Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Metabolomics identifies increases in the acylcarnitine profiles in the plasma of overweight subjects in response to mild weight loss: a randomized, controlled design study

Fig. 3

Correlation scatter plots of changes (Ī”) from baseline in the major acylcarnitines and visceral fat areas at L1 and L4 in the low calorie diet (LCD) group. a, b, c, d Correlations between Ī” hexanoylcarnitine, Ī” L-octanoylcarnitine, Ī” trans-2-dodecenoylcarnitine, Ī” 3,5-tetradecadiencarnitine and Ī” visceral fat area at L1, respectively. e, f, g, h Correlations between Ī” hexanoylcarnitine, Ī” L-octanoylcarnitine, Ī” trans-2-dodecenoylcarnitine, Ī” 3,5-tetradecadiencarnitine and Ī” visceral fat area at L4, respectively

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X